ODS Evidence-Based Review Program Recruits NCI Official
This article was originally published in The Tan Sheet
Executive Summary
The National Institutes of Health's Office of Dietary Supplements will help stimulate and prioritize supplement research by commissioning several evidence-based reviews from the Agency for Healthcare Research & Quality
You may also be interested in...
SAMe Benefits For Depression, Osteoarthritis, Liver Disease Noted By AHRQ
Dose escalation and risk benefit studies of SAMe for treatment of depression, osteoarthritis and liver disease are among the "promising" areas of future research involving the supplement ingredient identified by the Agency for Healthcare Research & Quality
SAMe Benefits For Depression, Osteoarthritis, Liver Disease Noted By AHRQ
Dose escalation and risk benefit studies of SAMe for treatment of depression, osteoarthritis and liver disease are among the "promising" areas of future research involving the supplement ingredient identified by the Agency for Healthcare Research & Quality
SAMe Benefits For Depression, Osteoarthritis, Liver Disease Noted By AHRQ
Dose escalation and risk benefit studies of SAMe for treatment of depression, osteoarthritis and liver disease are among the "promising" areas of future research involving the supplement ingredient identified by the Agency for Healthcare Research & Quality